Edwards Lifesciences (EW) Inventory (2009 - 2026)

Edwards Lifesciences has reported Inventory for 18 years, with the latest figure at $1.1 billion in Q1 2026.

• For the quarter ending Q1 2026, Inventory changed 0.46% year-over-year to $1.1 billion; the trailing twelve-month figure through Mar 2026 stood at $1.1 billion (changed 0.46% YoY), and the FY2025 full-year result was $1.1 billion, up 3.63% from the prior year.
• Inventory for Q1 2026 stood at $1.1 billion, down from $1.1 billion in the prior quarter.
• The five-year high for Inventory was $1.2 billion in Q1 2024, with the low at $730.6 million in Q1 2022.
• Average Inventory over 5 years is $999.9 million, with a median of $1.0 billion recorded in 2023.
• Year-over-year, Inventory jumped 36.24% in 2023 and slipped 7.74% in 2025.
• Tracing EW's Inventory over 5 years: stood at $875.5 million in 2022, then advanced by 3.2% to $903.5 million in 2023, then advanced by 20.28% to $1.1 billion in 2024, then climbed by 3.63% to $1.1 billion in 2025, then fell by 0.64% to $1.1 billion in 2026.
• The last three Inventory figures came in at $1.1 billion (Q1 2026), $1.1 billion (Q4 2025), and $1.1 billion (Q3 2025), per Business Quant data.

Peer Comparison